From Reuters.

Tylenol-maker Kenvue’s shares jumped 7% after hitting a record low, as analysts noted no new scientific evidence backed President Trump’s claim linking Tylenol use in pregnancy to autism. Regulators stress no proven causal link.

#News #Reuters #Newsfeed #tylenol #kenvue #trump #autism #pregnancy

Read the story here: https://reut.rs/3W8pKws

👉 Subscribe: http://smarturl.it/reuterssubscribe

Keep up with the latest news from around the world: https://www.reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en